L26/O-222 Assisted reproduction as a pronatalist vehicle to mitigate fertility decline: Europe versus Asia
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Chan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How do publicly funded IVF coverage policies and ART utilization, relative to fertility rate decline differ between European and Asian countries? Summary answer Although ART utilization increased, fertility rates continue to decline, with faster ART growth in Asia and more comprehensive public funding policies in Europe. What is known already Fertility rates have declined worldwide over recent decades, raising concerns about population aging, workforce contraction, and long-term economic sustainability. In response, many governments have adopted pronatalist strategies, including public financing of Assisted Reproductive Technology (ART). Financial barriers strongly influence ART access, and reimbursement is associated with increased utilization and reductions in childlessness. While many European countries provide national insurance coverage or government subsidies for ART, public support across Asia is often limited or decentralized. Cross-national analyses have largely focused on Europe, and to our knowledge, no study has systematically compared the two regions. Study design, size, duration We conducted a cross-national comparative analysis of publicly funded ART coverage policies, fertility trends, and ART utilization. Data was available for 44 European and 22 Asian countries. Countries were evaluated using a composite policy score quantifying the extent of public ART coverage. Fertility rates were assessed from 2010 to 2024, and annual ART cycle numbers from 2015 to 2019, to avoid COVID-19–related service disruptions. Outcomes were compared at the country level. Participants/materials, setting, methods Total fertility rates were obtained from the United Nations World Population Prospects and number of annual ART cycles were obtained from the International Committee for Monitoring Assisted Reproductive Technologies (ICMART) registry. The composite coverage scores incorporated the country’s financing model, scope of benefits, and eligibility criteria. Regional differences in coverage and fertility rate change were assessed using Welch two-sample t-tests, and percentage change in ART cycles was analyzed using linear regression adjusting for population size. Main results and the role of chance 41 (93.2%) European countries and 14 (63.6%) Asian countries provided some form of government assistance for ART. 3 (6.8%) European countries and 8 (57.1%) Asian countries provided no coverage at all. Among countries with public ART support, European countries had significantly higher average composite coverage scores than Asian countries (mean difference: 8.7 points, p < 0.05). Total fertility rates declined significantly in both regions between 2010 to 2024, with a significantly greater average rate of decline in Asia (Asia: -21.8% vs. Europe: -11.4%, p < 0.05). Specifically, between 2014 to 2019, there was also a significantly greater average rate of decline in Asia (Asia: -10.7% vs. Europe: –3.6%, p < 0.05). Data for the total number of ART cycles per year was available for 35 European countries and 8 Asian countries. From 2014 to 2019, the total number of cycles increased in both regions. In multivariable linear regression after controlling for population size, Asian countries demonstrated, on average, 76.6 percentage points greater growth in IVF cycles over five years compared with European countries (t(40)=2.62, p < 0.05). Although Asia experienced both a steeper fertility decline and faster growth in ART utilization, European countries maintained more comprehensive public ART coverage. Limitations, reasons for caution Policy scoring may simplify heterogeneous national programs, and cultural and societal factors influencing reproductive behavior may not be captured. ICMART data is incomplete for some countries, and fertility rates may also lag behind ART utilization due to delays between treatment and live births. Wider implications of the findings While public financing expands access to ART, it does not appear sufficient to reverse fertility decline. Further research is needed to identify which policy components most effectively increase ART utilization and reduce barriers to care. Trial registration number No
Zitieren
APA
Chan, Y., Dalton, C., & Hershlag, A. (2026). L26/O-222 Assisted reproduction as a pronatalist vehicle to mitigate fertility decline: Europe versus Asia. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.220
Vancouver
Chan Y, Dalton C, Hershlag A. L26/O-222 Assisted reproduction as a pronatalist vehicle to mitigate fertility decline: Europe versus Asia. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.220
BibTeX
@article{Chan2026,
author = {Chan, Y. and Dalton, C. and Hershlag, A.},
title = {L26/O-222 Assisted reproduction as a pronatalist vehicle to mitigate fertility decline: Europe versus Asia},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.220}
}
EUVIMED